Apotex, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Apotex, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13472
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Apotex, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Apotex, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Apotex, Inc. (Apotex or ‘the company’) is a privately-owned generic pharmaceutical company. The company produces and sells generic prescription drugs, fine chemicals, disposable plastics and non-prescription and private label medicines to healthcare providers, patients, governments and payers. It produces generic pharmaceuticals that are found in virtually every pharmacy and healthcare facility in Canada and are exported globally. The company operates its business through a network of joint ventures, affiliates, strategic alliances and distributors. Apotex carries out clinical trials at its Clinical Operations Facility in Canada. It has business presence in the Czech Republic, Australia, Mexico, Belgium, the Netherlands, Poland, the UK, Turkey and New Zealand. The company is headquartered in Ontario, Canada.

Scope

- Detailed information on Apotex, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Apotex, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Apotex, Inc. including a breakdown and examination of key business segments
- Intelligence on Apotex, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Apotex, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Apotex, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Apotex, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Apotex, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Apotex, Inc.: Company Overview
Apotex, Inc.: Overview and Key Facts
Apotex, Inc.: Overview
Apotex, Inc.: Key Facts
Apotex, Inc.: Key Employees
Apotex, Inc.: Key Employee Biographies
Apotex, Inc.: Major Products and Services
Apotex, Inc.: Company History
Apotex, Inc.: Management Statement
Apotex, Inc.: Key Competitors
Apotex, Inc.: Company Analysis
Apotex, Inc.: Business Description
Apotex, Inc.: SWOT Analysis
Apotex, Inc.: SWOT Overview
Apotex, Inc.: Strengths
Apotex, Inc.: Weaknesses
Apotex, Inc.: Opportunities
Apotex, Inc.: Threats
Apotex, Inc.: Corporate Financial Deals Activity
Apotex, Inc.: Financial Deals Overview
Apotex, Inc.: Targets and Partners
Apotex, Inc.: Top Deals 2015 – 2019YTD*
Apotex, Inc.: Advisors
Apotex, Inc.: Top Financial Advisors
Apotex, Inc.: Partnership
Apotex, Inc.: Divestments
Apotex, Inc.: Recent Developments
Apotex, Inc.: News and Events Summary
Apotex, Inc.: Business Expansion
Apotex, Inc.: Business Reorganization
Apotex, Inc.: Contracts
Apotex, Inc.: Corporate Governance
Apotex, Inc.: Financial Performance
Apotex, Inc.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Apotex, Inc.: Key Facts
Table 2: Apotex, Inc.: Key Employees
Table 3: Apotex, Inc.: Company History
Table 4: Apotex, Inc.: Key Competitors
Table 5: Apotex, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Apotex, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Apotex, Inc.: Targets and Partners
Table 8: Apotex, Inc.: Top Deals 2015 - 2019YTD*
Table 9: Apotex, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Apotex, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 11: Apotex, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 12: Apotex, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 13: Apotex, Inc.: News and Events Summary
Table 14: Apotex, Inc.: Business Expansion
Table 15: Apotex, Inc.: Business Reorganization
Table 16: Apotex, Inc.: Contracts
Table 17: Apotex, Inc.: Corporate Governance
Table 18: Apotex, Inc.: Financial Performance
Table 19: Apotex, Inc.: Regulatory and Legal Events

List of Figures
Figure 1: Apotex, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Apotex, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Apotex, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 4: Apotex, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 5: Apotex, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[Apotex, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Principia Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase inhibitor. It …
  • Uni-President Enterprises Corp:戦略・SWOT・企業財務分析
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Illumina Inc (ILMN):医療機器:M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • Consejo Superior de Investigaciones Cientificas:製薬・医療:M&Aディール及び事業提携情報
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management o …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Abramson Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Abramson Cancer Center, formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrati …
  • Angelo Iafrate Construction Co:企業の戦略・SWOT・財務情報
    Angelo Iafrate Construction Co - Strategy, SWOT and Corporate Finance Report Summary Angelo Iafrate Construction Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SolarEdge Technologies Inc (SEDG):企業の財務・戦略的SWOT分析
    SolarEdge Technologies Inc (SEDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sequa Petroleum NV (MLSEQ):企業の財務・戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company. It develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Europe, Central and West Africa and the Middle East. Sequa Petroleum has a large development and producing area in N …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • LG Electronics, Inc.:戦略・SWOT・企業財務分析
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Wacker Chemie AG (WCH):電力:M&Aディール及び事業提携情報
    Summary Wacker Chemie AG (Wacker) develops, manufactures and markets various chemical and semiconductor materials. It offers a range of silicone fluids and emulsions, resins, elastomers, sealants and silanes. The company manufactures binders and polymeric additives such as dispersible polymer powder …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TBG Diagnostics Ltd (TDL)-医療機器分野:企業M&A・提携分析
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical researc …
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • The United India Insurance Co Ltd:企業の戦略・SWOT・財務情報
    The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • INEOS Olefins & Polymers Europe:企業の戦略的SWOT分析
    INEOS Olefins & Polymers Europe - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆